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a b s t r a c t
The group of pulmonary valve and pulmonary artery primary tumors is the most frequently
represented by schwannomas, myxomas, papillary ﬁbroelastomas, primary choriocarcino-
mas and sarcomas. These tumors are very rare. The most common clinical manifestation of
pulmonary artery tumor is dyspnea, followed by chest pain, cough, and haemoptysis.
A case of 44-year-old male with history of progressive dyspnea, fever, cough, and weight
loss is presented. Imaging methods showed large saddle embolus in the right ventricle
outﬂow tract, pulmonary valve and pulmonary artery trunk. He was admitted to a hospital
for anticoagulation therapy. Since there was no clinical improvement, the patient had to
undergo surgery. Nearly full artery caliber ﬁlling tumor in pulmonary artery was found with
its origin in pulmonary valve. Next exploration showed several little tumors in right ventricle
outﬂow tract and also in pulmonary artery. The ﬁnal outcome of histological examination
showed the presence of leiomyosarcoma high grade 3.
Presented case highlights that pulmonary artery tumor should always be included in the
differential diagnosis of pulmonary embolism, especially if the symptoms progress while on
adequate anticoagulation, and if any risk factor for deep vein thrombosis is not present.
Unfortunately, prognosis of pulmonary artery sarcomas is usually dismal, secondary to late
diagnosis.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.




Primary tumors of the pulmonary artery and pulmonary valve
are rare and may pose a difﬁcult clinical diagnosis. The group
of these tumors includes schwannomas, myxomas, papillary
ﬁbroelastomas, primary choriocarcinomas and sarcomas
[1–4]. Pulmonary artery sarcomas (PASs) are the most common* Corresponding author at  : Department of Cardiac Surgery, VUSCH Ltd      
E-mail address: topyto@gmail.com (T. Toporcer).
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0010-8650/# 2015 The Czech Society of Cardiology. Published by Elseprimary tumors of the pulmonary artery, but the incidence of
this diagnosis is extremely rare. PAS was ﬁrst described in
autopsy by Mandelstamm in 1923 [5]. There have been
reported around 200 cases of PASs in the literature up to date
[6].
PASs is predominantly presented among patients from
their third to seventh decade, with an average age of 49 years
[7,8]. PASs are always highly malignant, women are involved
twice as often as men [9]. The most common clinical., Ondavská 8, 04001 Ko    šice, Slovakia. Tel.: +421 557891210.    
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Table 1 – Incidence of PASs subtypes described by several authors [8,16,17].
Author: Cox et al. Nonomura et al. Gaumann et al.
Year 1997 1988 2008
Number of patients 138 110 18
Subtype of PASs and incidence in groups
Undifferentiated sarcoma 31% 31%
Leiomyosarcoma 16% 21%
Spindle-cell sarcoma 14%
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(45%), cough (42%), and haemoptysis (24%) [6,10]. The presence
of these symptoms often causes misdiagnosis of pulmonary
embolism [7]. Systematic symptoms of PASs are less rare and
they include weight loss (21%), syncope (9%), and fever (8%) [6].
PASs more frequently affect segments of the pulmonary artery
with large diameter, predominantly the trunk (85%), right
(71%) and left (65%) arteries. The pulmonary valve (32%) and
right ventricular outﬂow tract (10%) are involved less fre-
quently [6,11–14].
There are two major categories of PASs known: intimal
and mural. The intimal PASs show an intraluminal polypoid
growth pattern and histological evidence of ﬁbroblastic and
myoﬁbroblastic differentiation. These subtypes are typically
positive for vimentin and osteopontin and negative for
endothelial markers. The mural PASs show characteristics
related to the soft tissue sarcomas [8,15]. There have been
many histopathological subtypes of PASs reported, including
undifferentiated sarcomas, leiomyosarcomas, rhabdomyosar-
comas, ﬁbrosarcomas, chondrosarcomas and osteosarcomas
[6]. Table 1 shows the incidence of PASs subtypes described by
several authors (Table 1) [8,16,17].Fig. 1 – Computer tomography image (high of left pulmonary
artery distance) – no sign of thrombus or tumor.Case report
A 44-year-old male with medical history of appendectomy and
hepatitis was accepted to the emergency room with several
week history of progressive dyspnea, fever, cough, and weight
lost of 4 kg. He denied chest pain. Initial transthoracic
echocardiography showed right ventricle dilatation and
pulmonary hypertension. Contrast CT scan of chest was
performed and revealed what appeared to be a large saddle
embolus in the right ventricle outﬂow tract, pulmonary valve
and pulmonary artery trunk (Figs. 1–4). According to these
ﬁndings the patient was admitted to a hospital for antic-
oagulation therapy using low molecular weight heparin and
warfarin. Since there was no clinical improvement recorded,
the patient was transported to the cardiology institute.
Repeated transthoracic echocardiography was performed
with suspicion of pulmonary valve and right ventricle outﬂow
tract tumor. Ventilation/perfusion scan recorded moderate
asymmetry with declining of signal in right lung without
evident segmental defects. Coronarography did not reveal any
coronary artery stenosis. The patient was indicated for cardiac
surgery.Fig. 2 – Image of computer tomography (high of right
pulmonary artery distance) – no sign of thrombus or tumor
in right pulmonary artery/defect of contrast filling in
pulmonary artery trunk.
Fig. 3 – Image of computer tomography (high of pulmonary
artery trunk) – defect of contrast filling nearly full artery
caliber.
Fig. 4 – Image of computer tomography (high of left coronary
artery distance) – defect of pulmonary artery contrast filling
nearly full artery caliber.
Fig. 5 – Preoperative picture. Tumor is filling nearly full
pulmonary artery caliber.
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a cardiopulmonary bypass was established and the heart was
arrested using an anterograde intermittent cold blood cardi-
oplegic solution. Pulmonary artery was opened and nearly full
artery caliber ﬁlling tumor was found (Fig. 5). The tumor had its
origin in pulmonary valve. Tumor including pulmonary valve
was excised and subsequent histological examination revealed
sarcoma (Fig. 6). Next exploration showed several little tumors
in right ventricle outﬂow tract and also in pulmonary artery.
Such ﬁnding was determined as surgically unresectable.
Pulmonary valve was replaced by a biological prosthesis
St. Jude Medical Epic. Pulmonary artery and right ventricle
outﬂow tract was sutured using pericardial patch (Fig. 7). The
early post-operative period was without complications.
The ﬁnal outcome of histological examination documentedthe presence of leiomyosarcoma high grade 3 positive for actin,
desmin, and vimentin and negative for caldesmon. Resection
margins were positive for tumor cells. The patient was
discharged and adjuvant chemotherapy initiated.
Discussion
Eventhough sarcoma is the most common pulmonary artery
tumor, it is very rare in this location. Diagnosis is usually
delayed because of late symptoms. In fact, symptoms mimic
chronic pulmonary embolism, as in described case report.
Systemic symptoms of PASs are useful to determine a right
diagnosis, however, these symptoms are not frequent [18]. One
of the diagnostic methods is computer tomography (CT), with
some speciﬁc imaging features to distinguish PAS from
pulmonary embolism: (1) pulmonary embolism is more
frequently peripheral (75%) and bilateral (83%), whereas PAS
is presented as unilateral and central polypoid ﬁlling defect
(80%); (2) in contrast to the abrupt narrowing and cut-off often
recorded in pulmonary embolism, PASs form a contiguous soft
smooth tapering tissue, extending from the pulmonary trunk to
the peripheral arteries; (3) PASs cause complete unilateral ﬁlling
of the vascular lumen at CT and complete unilateral defect at
ventilation/perfusion scan (90%), while this phenomenon is not
observed in pulmonary embolism; (4) transmural invasion is
presented only in PASs; and (5) parenchymal abnormalities
observed in PASs rarely touch the pleura (Table 2) [8,18–20]. In
presented case report, only the ﬁrst three differences were
recorded. Despite magnetic resonance imaging (MRI) was not
performed in presented patient, MRI is also useful diagnostic
method for distinguishing PAS and pulmonary embolism. Low-
intensity heterogeneous features on T1-weighted images and
peripheral enhancement of the thickened pulmonary artery
Fig. 6 – Excised tumor.
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have classically been thought to support a diagnosis of PASs or
other pulmonary artery tumor on MRI [18,21]. Fluorodeoxyglu-
cose (FDG)/positron emission tomography can also distinguish
tumor and thrombus, as the maximum standardized uptake
value of pulmonary artery sarcomas (7.63  2.21) is higher than
that of pulmonary emboli (2.31  0.41) [6,22–24]. Other char-
acteristics, such as the absence of risk factors for deep veinFig. 7 – Preoperative picture. Pulmonary artery and right
ventricle outflow tract sutured using pericardial patch.thrombosis and high erythrocytes sedimentation rate should
raise the suspicion of a process other than pulmonary
embolism. Lack of response to anticoagulation therapy and
thrombolysis leads toward diagnosis of pulmonary artery
tumor, as mentioned in our case report and some other
publications [7,18]. The only method to deﬁnitely differentiate
diagnosis between PASs and pulmonary embolism is histopa-
thology; tissue pattern can be obtained either by angioscopy or
by surgery [9].
Surgery is the most effective treatment of intimal sarcoma
and is successful if total resection is performed [25].
Cardiosurgery can be extended by concomitant lung surgery,
if combined surgical approach is needed [26]. Some authors
complete the operation by pneumonectomy with no clear
proof for survival beneﬁt [9]. In presented case, only incom-
plete resection was executable because of the size and location
of the tumor. Palliative surgical procedure and pulmonary
valve replacement was performed. The optimal adjuvant
treatment is still unclear. Chemotherapy or radiation therapy
after surgery can improve survival and/or progression-free
interval [15]. Chemotherapy is palliative for most of the patients
with unresectable or metastatic disease. Ifosfamide and
doxorubicin are standard drugs, single agent doxorubicin being
considered the drug of choice. For younger patients with
aggressive tumor, high doses of ifosfamide with doxorubicin are
used. Response rate to this therapy is 50–60% [15]. Trabectidin, a
selective inhibitor of DNA transcription, has shown activity in
phase I/II clinical trials in advanced disease refractory to
conventional treatment with a low rate of objective remission,
but with high rate of interruption of disease progression [27,28].
The use of targeted molecular therapies against the proto-
oncogene c-Kit, epidermal growth factor receptor (EGFR), and
vascular endothelial growth factor receptor (VEGFR) is being
investigated [15,29].
Table 2 – Characteristics of pulmonary artery sarcoma compared to pulmonary embolism [17,19].
Pulmonary artery sarcoma Pulmonary embolism
Localization of ﬁlling defect Unilateral/central Peripheral, bilateral
Character of ﬁlling defect Continuous from pulmonary trunk Abrupt narrowing
Complete unilateral ventilation/perfusion defect Typically Very rarely
Transmural invasion Typically Never
Pleura invasion Typically Never
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 3 7 1 – e 3 7 6 e375Prognosis of PASs is usually unfavorable, secondary to late
diagnosis. Direct extension to lung, heart, pleura, and
mediastinum is more common than extrathoracic metastasis.
Pulmonary and mediastinal metastasis are present in 50% of
patients at the time of diagnosis [6]. Patients undergoing
curative resection have median survival of 36.5 months
compared to 11 months survival for those undergoing
incomplete resection. Multimodality treatment leads to longer
patient survival compared to single-modality treatment [30].
Survival of patients also varies according to a histologic
subtype, with better prognosis for leiomyosarcoma than for
undifferentiated sarcoma, or rhabdomyosarcoma as the least
favorable type [31]. Patients who are not treated by surgical
means, or those that do not respond to chemotherapy have
very poor prognosis [32].
There is one case of spontaneous regression of primary
pulmonary artery sarcoma published in the literature.
Uematsu et al. presented case of 76 years old man with
unresectable PAS with invasion into the left atrium and to the
left lung. During 22 months patient observation there was a
complete regression of primary tumor recorded. On the other
hand patient died because of the tumor metastasis complica-
tions. Primary tumor regression was explained by insufﬁcient
blood support due to enormous fast tumor growth [33].
Conclusion
Our case report emphasizes that PAS should always be
included in the differential diagnosis of pulmonary embolism
especially if symptoms progress despite adequate antic-
oagulation therapy, and if any risk factor for deep vein
thrombosis is not present. Prognosis of pulmonary artery
sarcomas is usually dismal, secondary to late diagnosis.
Patients not treated by surgery and no respond to chemother-
apy have very poor outcome.
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